Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension

McGoon, Michael D.; Krichman, Abby; Farber, Harrison W.; Barst, Robyn J.; Raskob, Gary E.; Liou, Theodore G.; Miller, Dave P.; Feldkircher, Kathy; Giles, Scorr
August 2008
Mayo Clinic Proceedings;Aug2008, Vol. 83 Issue 8, p923
Academic Journal
The Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL) has been designed to meet the need for current information about patients with pulmonary arterial hypertension (PAH). The main objectives of REVEAL are to better define and understand PAH and to assess the consequences of treatment strategies. REVEAL is collecting clinically relevant data from 3500 consecutively enrolled patients with confirmed PAH diagnoses. Outcomes will be evaluated longitudinally and compared according to the baseline classification of PAH. The primary outcome for group comparisons will be survival. Collected data include World Health Organization functional class, 6-minute walk distance, cardiopulmonary exercise testing, pulmonary function test results, hemodynamic measurements, functional status, hospitalizations, and death. REVEAL will be the richest source of data on patients with World Health Organization group I PAH.


Related Articles

  • Pulmonary Hypertension Complicating Systemic Hypertension, Is Diastolic Dysfunction the Culprit? Dusaj, Raman S.; Mukherjee, Monica; Furmark, Lena; Katz, Richard J.; Choi, Brian G.; Lewis, Jannet F. // Research Journal of Cardiology;Jan-Mar2014, Vol. 2 Issue 1, p1 

    Background: Elevation in PA pressures has been observed by 2D echo in some but not all hypertensive patients. The mechanism and hemodynamic impact of pulmonary hypertension in these patients remains unclear. Methods: We reviewed echoes of all patients referred with systemic hypertension between...

  • Reflections on the Scientific Sessions.  // Advances in Pulmonary Hypertension;2014, Vol. 13 Issue 3, p141 

    Information about topics discussed at a roundtable on the highlights of the International Pulmonary Hypertension Conference and Scientific Sessions held in Indianapolis, Indiana on June 20-22, 2014 is presented. The topics of the roundtable include hemodynamics, pulmonary artery hypertension...

  • A low resting heart rate at diagnosis predicts favourable long-term outcome in pulmonary arterial and chronic thromboembolic pulmonary hypertension. A prospective observational study. Hildenbrand, Florian F.; Fauchère, Ivan; Huber, Lars C.; Keusch, Stephan; Speich, Rudolf; Ulrich, Silvia // Respiratory Research;Sep2012, Vol. 13 Issue 9, p1 

    Background: A low resting heart rate (HR) is prognostically favourable in healthy individuals and in patients with left heart disease. In this study we investigated the impact of HR at diagnosis on long-term outcome in patients with differently classified precapillary pulmonary hypertension...

  • Epidemiology.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 3, p86 

    The article presents abstracts on medical topics which include the existence of pulmonary arterial hypertension (PAH) in dasatinib treated patients, the impact of air travel on pulmonary hypertensive patients and the Registry to Evaluate Early and Long-Term (REVEAL) PAH in disease management.

  • The impact of pulmonary arterial pressure on exercise capacity in mild-to-moderate cystic fibrosis: a case control study.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 4, p133 

    The article focuses on a case control study which explores the impact of post-exercise pulmonary artery systolic pressure (PASP) on patients with mild-to moderate cystic fibrosis (CF). It suggests higher post-exercise (PASP) among CF patients without pulmonary hypertension (PH) at rest....

  • Insights From the Fifth World Health Organization Symposium Working Group: Definitions and Diagnosis of Pulmonary Hypertension. Torres, Fernando // Advances in Pulmonary Hypertension;2014, Vol. 13 Issue 1, p27 

    During the Fifth World Symposium on Pulmonary Hypertension, the working group on diagnosis and assessment was charged with evaluating the definition of pulmonary arterial hypertension (PAH) as it was established at the Fourth World Symposium. The group also covered related topics such as...

  • Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Mainguy, Vincent; Maltais, François; Saey, Didier; Gagnon, Philippe; Martel, Simon; Simon, Mathieu; Provencher, Steeve // Thorax;Feb2010, Vol. 65 Issue 2, p113 

    Background A majority of patients with idiopathic pulmonary arterial hypertension (IPAH) display persistent exercise intolerance despite new specific therapies. Whether patients with IPAH exhibit peripheral muscle dysfunction that may contribute to this limitation remains unknown. The hypothesis...

  • Chronic Thrombotic Obstruction of Major Pulmonary Arteries. Moser, Kenneth M.; Spragg, Roger G.; Utley, Joseph; Daily, Pat O. // Annals of Internal Medicine;Sep83, Vol. 99 Issue 3, p299 

    Examines patients with pulmonary hypertension associated with chronic thrombotic obstruction of major pulmonary arteries. Clinical features of patients with pulmonary hypertension; Diagnosis of the disease; Results of thromboendarterectomy.

  • Primary Pulmonary Hypertension Treated with Oral Phentolamine. Ruskin, Jeremy N.; Hutter Jr., Adolph M. // Annals of Internal Medicine;May79, Vol. 90 Issue 5, p772 

    Presents information on a study which evaluated the treatment trial of a patient with symptomatic primary pulmonary artery hypertension with parenteral and oral phentolamine. Information on primary pulmonary artery hypertension; Medical history of the patient; Results and discussion.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics